Prima BioMed Ltd (PBMD.OQ)

PBMD.OQ on NASDAQ Stock Exchange Global Market

1.30USD
2 Jul 2015
Change (% chg)

$-0.09 (-6.47%)
Prev Close
$1.39
Open
$1.44
Day's High
$1.44
Day's Low
$1.26
Volume
81,735
Avg. Vol
614,102
52-wk High
$6.47
52-wk Low
$0.47

PBMD.OQ

Chart for PBMD.OQ

About

Prima BioMed Ltd (Prima) is an Australia-based biotechnology company. The Company is engaged in the development of immunotherapeutic products for the treatment of cancer. The Company's lead product is CVac, which is an autologous dendritic cell-based product. Its CVac is in clinical trials for ovarian cancer patients in... (more)
No analyst recommendations are available for PBMD.OQ.

Overall

Beta: 1.98
Market Cap(Mil.): $106.84
Shares Outstanding(Mil.): 1,751.49
Dividend: --
Yield (%): --

Financials

  PBMD.OQ Industry Sector
P/E (TTM): -- 454.60 39.81
EPS (TTM): -0.01 -- --
ROI: -46.44 -4.37 16.23
ROE: -52.05 -5.27 17.36
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$1,000.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks